[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wound Closure Devices - Medical Devices Pipeline Assessment, 2019

December 2019 | 610 pages | ID: W03587017FAEN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Wound Closure Devices - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Wound Closure Devices - Medical Devices Pipeline Assessment, 2019' provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Wound Closure Devices Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Wound Closure Devices - Pipeline Products by Stage of Development
3.2 Wound Closure Devices - Pipeline Products by Segment
3.3 Wound Closure Devices - Pipeline Products by Territory
3.4 Wound Closure Devices - Pipeline Products by Regulatory Path
3.5 Wound Closure Devices - Pipeline Products by Estimated Approval Date
3.6 Wound Closure Devices - Ongoing Clinical Trials

4 WOUND CLOSURE DEVICES - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development
4.2 Wound Closure Devices - Pipeline Products by Stage of Development

5 WOUND CLOSURE DEVICES COMPANIES AND PRODUCT OVERVIEW

6 WOUND CLOSURE DEVICES- RECENT DEVELOPMENTS

7 APPENDIX

LIST OF TABLES

Table 1: Wound Closure Devices - Pipeline Products by Stage of Development
Table 2: Wound Closure Devices - Pipeline Products by Segment
Table 3: Wound Closure Devices - Pipeline Products by Territory
Table 4: Wound Closure Devices - Pipeline Products by Regulatory Path
Table 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Table 6: Wound Closure Devices - Ongoing Clinical Trials
Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Wound Closure Devices - Pipeline Products by Stage of Development
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PuraStat Hemostat - Product Status
Table 11: PuraStat Hemostat - Product Description
Table 12: TDM-511 - Product Status
Table 13: TDM-511 - Product Description
Table 14: TDM-623 - Product Status
Table 15: TDM-623 - Product Description
Table 16: TDM-651 - Product Status
Table 17: TDM-651 - Product Description
Table 18: 3-D Matrix Ltd - Ongoing Clinical Trials Overview
Table 19: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection
Table 20: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
Table 21: PuraStat Hemostat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding
Table 22: PuraStat Hemostat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
Table 23: ACell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: MicroMatrix - Product Status
Table 25: MicroMatrix - Product Description
Table 26: ACell Inc - Ongoing Clinical Trials Overview
Table 27: MicroMatrix - A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix with Cytal Wound Matrix 2-Layer to Standard of Care in Patients with Stage 3 or 4 Pressure Injuries
Table 28: MicroMatrix - The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
Table 29: MicroMatrix - Use of Cytal Wound Matrix and MicroMatrix for the Management of Wounds
Table 30: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Actamax Adhesion Barrier - Product Status
Table 32: Actamax Adhesion Barrier - Product Description
Table 33: Actamax Surgical Materials LLC - Ongoing Clinical Trials Overview
Table 34: Actamax Adhesion Barrier - A Randomized, Controlled, Multi-center Study to Assess the Safety and Efficacy of Actamax Adhesion Barrier in Women undergoing Laparoscopic Abdominopelvic Surgery with a Myomectomy Followed by Second Look Laparoscopy (SLL)
Table 35: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 36: CUTIS - Product Status
Table 37: CUTIS - Product Description
Table 38: VIVO - Product Status
Table 39: VIVO - Product Description
Table 40: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Large Wounds Closure Device - Product Status
Table 42: Large Wounds Closure Device - Product Description
Table 43: LiquiBand - Product Status
Table 44: LiquiBand - Product Description
Table 45: LiquiBand Exceed - Product Status
Table 46: LiquiBand Exceed - Product Description
Table 47: LiquiBand Flow Control - Product Status
Table 48: LiquiBand Flow Control - Product Description
Table 49: Next Generation Internal Fixation And Sealant Device - Product Status
Table 50: Next Generation Internal Fixation And Sealant Device - Product Description
Table 51: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview
Table 52: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery
Table 53: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Rivelin Plain Patch - Product Status
Table 55: Rivelin Plain Patch - Product Description
Table 56: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: VersaWrap Adhesion Barrier - Product Status
Table 58: VersaWrap Adhesion Barrier - Product Description
Table 59: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Biohybrid Membrane - Product Status

LIST OF FIGURES

Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development
Figure 2: Wound Closure Devices - Pipeline Products by Segment
Figure 3: Wound Closure Devices - Pipeline Products by Territory
Figure 4: Wound Closure Devices - Pipeline Products by Regulatory Path
Figure 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date
Figure 6: Wound Closure Devices - Ongoing Clinical Trials

COMPANIES MENTIONED

3-D Matrix Ltd
ACell Inc
Actamax Surgical Materials LLC
Adhesys Medical GmbH
Advanced Medical Solutions Group plc
AFYX Therapeutics A/S
Alafair Biosciences Inc
Albert Ludwigs University of Freiburg
Aleo BME Inc
Alumend LLC
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APRUS Bio-Medical Innovations Pvt Ltd
ARC Medical Devices Inc
Arch Therapeutics Inc
Arizona State University
Aura Medsystems, Inc.
BaroStitch
Baxter Healthcare Corp
Baxter International Inc
Bayer AG
Bergen Medical Products Inc
Beth Israel Deaconess Medical Center Inc
BioActive Polymers in Lund AB
Biomedica Management Corp
Biom'Up SAS
BNC Korea Co Ltd
Bolder Surgical LLC
Boston University
C. R. Bard Inc
Calmare Therapeutics Inc
CardioCommand Inc
Cellphire Inc
Ceramicos Para Aplicacoes Medicas SA
Clemson University
Cohera Medical Inc
Columbia University
Covalent Medical, Inc. (Inactive)
Covalon Technologies Ltd
Covidien plc
Cresilon Inc
CryoLife Inc
DSM Biomedical BV
Duke University
Elastagen Pty Ltd
Emory University
Emrge LLC
Endomedix Incorporated
Entegrion Inc
Epic MD
ES Vascular Ltd.
Ethicon Endo-Surgery Inc
Ethicon US LLC
ETX Pharma Inc
FzioMed Inc
Gamma Therapeutics Inc
GATT Technologies BV
gel-e Inc
Genzyme Corp
Grifols USA LLC
Haemostatix Ltd
Hemostasis LLC
HLL Lifecare Ltd
HyperBranch Medical Technology Inc
Innocoll Technologies Ltd
Institute of Molecular Biology of Parana
Integra LifeSciences Holdings Corp
InVivo Therapeutics Corp
IonMed Ltd.
Johns Hopkins University
Keratin Biosciences Inc
Kollodis BioSciences Inc
Kuros Biosciences AG
Kytogenics Pharmaceuticals Inc
Laser Tissue Welding, Inc.
Latch Medical Ltd
Leader Biomedical Europe BV
Lenvitz Medical Solutions Pvt Ltd
Life Care Medical Devices Ltd
LifeBond Ltd
Luna Innovations Inc
Magen OrthoMed Ltd
Massachusetts Institute of Technology
Maxigen Biotech Inc
Medical Ingenuities LLC
Medisse BV (Inactive)
Medytox Inc
MLM Biologics Inc
N8 Medical Inc
National University of Singapore
Northwestern University
OptMed, Inc.
PetVivo Holdings Inc
Pharming Group NV
Polyganics BV
Progress and Health Foundation
Protege Biomedical
Protein Polymer Technologies Inc (Inactive)
Proximate Concepts LLC
Purdue University
Regenics AS
Resorba GmbH
Rice University
Rutgers The State University of New Jersey
Samyang Biopharmaceuticals Corp
Sanara MedTech Inc
Sanofi Biosurgery Inc
Sea Run Holdings Inc
Sealantis Ltd.
Seikagaku Corp
Seraffix Ltd
Shanghai Haohai Biological Technology Co Ltd
Sheba Medical Center
St Teresa Medical Inc
Stanford University
Starling Surgical
STB Lifesaving Technologies
Surgical Energetics LLC
Surgical Sealants, Inc.
Tectum
Teijin Pharma Ltd
Texas A&M University
The Medicines Company
Therus Corporation
Thrombotargets Corp
Tissium SA
TransEnterix Inc
Tribos LLC
Tricol Biomedical Inc
United Health Products, Inc.
University of Akron
University of Grenoble Alpes
University of Kansas
University of Pennsylvania
University of South Florida
University of Toledo
Virginia Commonwealth University
WoundZipper Inc
Xcede Technologies Inc
Yale University
ZSX Medical LLC


More Publications